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resumo 
 
 
A photobacteriose de peixes é uma infecção sistémica de evolução rápida, 
causada pela bactéria Gram-negativa Photobacterium damselae subsp. 
piscicida (Phdp), que provoca elevadas mortalidades em várias espécies de 
peixes marinhos. Nos animais infectados, a Phdp dissemina-se na corrente 
sanguínea e secreta a AIP56, uma exotoxina apoptogénica que permite ao 
agente infeccioso escapar à defesa fagocítica do hospedeiro através da 
indução da morte por apoptose dos fagócitos. Embora tenha sido demonstrado 
que a AIP56 é um factor-chave da virulência da Phdp e embora a patologia 
associada à AIP56 esteja bem caracterizada, os alvos moleculares da toxina e 
as vias moleculares por ela afectadas continuam por desvendar. Dados 
recentes revelaram que a AIP56 é uma toxina do tipo AB, contendo um 
domínio N-terminal (domínio A) de metaloprotease responsável pela actividade 
catalítica e um domínio C-terminal (domínio B) envolvido na ligação e 
internalização da toxina pelas células. O domínio N-terminal da AIP56 é 
homólogo ao non-LEE encoded effector C (NleC), um efector presente em 
várias bactérias patogénicas entéricas e secretado por um sistema de 
secreção do tipo III. Foi recentemente descrito que o NleC corta e inactiva o p-
65 do NF-kB. Contudo, continua por investigar se a AIP56 também tem como 
alvo o p-65 do NF-kB e se existe uma relação entre um possível corte do p65 e 
consequente inactivação do NF-kB e a actividade apoptogénica da toxina. 
Embora se tenha avaliado a susceptibilidade de várias linhas de celulares de 
mamíferos à AIP56, pelo facto de não se ter observado a ocorrência de 
apoptose como consequência da exposição à toxina em nenhuma das linhas 
testadas, até ao momento, a actividade da AIP56 tem vindo a ser estudada 
usando um modelo ex vivo que consiste em leucócitos peritoneais isolados de 
robalo. A especificidade observada poderá resultar do facto de os receptores 
de membrana para a AIP56 existirem nos fagócitos dos hospedeiros 
susceptíveis e estarem ausentes nas células de mamífero, sugerindo que se a 
AIP56 entrasse nas células de mamífero, poderia ser capaz de induzir 
apoptose dessas células. A existência de um modelo celular de mamífero para 
estudar os detalhes da actividade da AIP56 seria muito vantajosa, pois 
permitiria utilizar um vasto leque de ferramentas disponíveis comercialmente 
que não existem ou não podem ser usadas em estudos com células de robalo. 
Neste trabalho testamos e optimizamos diferentes protocolos para introduzir a 
AIP56 e proteínas derivadas da AIP56 em células HeLa. Dos resultados 
obtidos, conclui-se que os métodos mais eficazes para a introdução da toxina 
foram a transfecção por método químico e a utilização do sistema LF/PA do 
Bacillus anthracis. A transfecção química permite não só obter e estudar 
células transfectadas de forma transiente, mas também desenvolver linhas 
celulares transfectadas estáveis. 
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abstract 
 
Fish photobacteriose is a bacterial systemic and deadly infection with rapid 
course and very high mortalities, caused by the Photobacterium damselae 
subsp. piscicida (Phdp). Phdp spreads through the bloodstream and secretes 
the apoptogenic exotoxin AIP56 allowing the pathogen to avoid phagocytosis 
by inducing the apoptotic death of the host phagocytes. Although AIP56 was 
found to be a key virulence factor of Phdp and the AIP56-related pathology has 
been well characterized, the molecular targets of the toxin and the molecular 
pathways it affects/modulates remain to be disclosed. Recent data revealed 
that AIP56 is an AB-toxin, possessing an N-terminal metalloprotease domain (A 
domain) responsible for the catalytic activity of the toxin and a C-terminal 
domain (B domain) involved in the binding/internalization of the toxin into the 
cells. The N-terminal domain of AIP56 is homologous to the non-LEE encoded 
effector C (NleC), a type III secreted effector of enteric pathogenic bacteria that 
cleaves and inactivates the p65 of NF-kB. However, it remains to be 
investigated if AIP56 also targets NF-kB p65 and if NF-kB p65 inactivation by 
AIP56 is linked to the apoptogenic activity of the toxin. So far, AIP56 activity 
has been being studied using an ex vivo model consisting of freshly isolated 
sea bass peritoneal leukocytes because although the susceptibility of several 
mammalian cell lines to AIP56 has been assessed, no apoptosis was observed 
in any of the cell lines tested. This specificity of the toxin may result from the 
existence of receptors for AIP56 in phagocytes of susceptible hosts and their 
absence in mammalian cells and suggests that if AIP56 was able to enter 
mammalian cells, it would be able to induce apoptosis in those cells. The 
existence of a mammalian cell model for studying in detail the AIP56 activity 
would be very advantageous, because there is much more availability of tools 
to study mammalian cells than sea bass cells. In this work, we tested and 
optimized different protocols for the intracellular delivery of AIP56 and AIP56-
related proteins into HeLa cells. We found that the most efficient methods for 
intracellular toxin delivery were chemical transfection with toxin-encoding 
expression vectors and the use of the LF/PA system of Bacillus anthracis. The 
chemical transfection allows not only to obtain and study transiently transfected 
cells, but also to develop stable transfected cell lines. 
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Fish photobacteriosis 
Fish photobacteriosis is a bacterial septicemia caused by Photobacterium 
damselae subsp. piscicida (Phdp). This Gram-negative bacterium is highly 
pathogenic for wild and cultured marine fish, affecting more than 20 fish species 
worldwide. In the acute form, photobacteriosis is a systemic and deadly infection 
with rapid course and very high mortalities [1, 2].  
Fish photobacteriosis was first reported in wild populations of white perch 
(Morone americanus) and striped bass (Morone saxatilis) in 1963 in Chesapeake 
Bay, USA. In 1969, the pathogen has become economically important, as it started 
to cause losses of fish in Japan, compromising the Japanese fish farming industry 
[3]. In 1990, many outbreaks of photobacteriosis happened in cultured sea bass 
(Dicentrarchus labrax) and sea bream (Sparus aurata) in different European 
countries [1].  Although epizootic can be controlled by treatment with antibiotics 
and some aquacultures apply immunoprophylaxis in broodstock and juveniles, 
presently, fish photobacteriosis continues to be a serious problem in the intensive 
culture of different fish species in the Mediterranean area and Japan, causing 
considerable economic losses in the marine aquaculture industry in these regions 
[3, 4]. 
External pathological signs of fish photobacteriosis are not immediately 
obvious, as surface lesions are usually absent in infected fish. However, a dark 
coloration and a decrease in natatorium activity may occur. Internally, infected fish 
exhibit haemorrhagic septicemia, and granulomatous lesions in the kidneys, 
spleen and liver due to the accumulation of bacteria [5]. It has been shown that in 
infected fish, Phdp spreads through the bloodstream, colonizes various internal 
organs and secretes the apoptogenic exotoxin AIP56 (apoptogenic inducing 
protein of 56 kDa), that allows the pathogen to avoid phagocytosis by inducing the 
apoptotic death of the host phagocytes [2]. Phagocytosis is the first crucial step of 
the antibacterial host defence mechanism against extracellular pathogens. Many 
of these pathogens are able to escape from phagocytosis through the use of 
molecules that efficiently kill host phagocytes. A mechanism used by extracellular 
pathogens to successfully escape phagocytosis is the production of molecules that 
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destroy the phagocytes of the host, usually macrophages and neutrophils, by 
apoptosis.  
Apoptosis is an evolutionarily conserved process used by multicellular 
organisms to developmentally regulate cell number or to eliminate cells that are 
potentially detrimental to the organism, as an instrument for the disposal of 
unwanted cells during embryonic development, during normal cell turnover in 
proliferating tissues and in pathological situations, maintaining the homeostasis 
[6]. A cell undergoing apoptosis loses the connections with other cells and the 
extracellular matrix and rounds up. It begins to display the protrusions of the 
plasma membrane, usually referred to as „blebs‟. Blebs can be seen by some time 
protruding and retracting. Condensation of the cell nucleus occurs, often starting 
as a condensed ring along the nuclear envelope, and then extends to encompass 
the entire nucleus. The condensed nucleus may disassemble into multiple 
fragments. The cell condenses and is reorganized into so-called „apoptotic bodies‟. 
Caspases are activated and their activity is required for the observed changes in 
morphology [6-10]. 
Under normal conditions, apoptotic cells and apoptotic bodies are 
eliminated by removal via scavengers engaged by the exposure of engulfment 
signals during the implementation phase of apoptosis [11]. This is a mechanism 
for eliminating cells with the participation of a scavenger cell to engulf and digest 
by heterolysis the apoptosing cell before post-apoptotic secondary necrosis 
occurs, that is, while the cell in apoptosis is still surrounded by a nearly intact 
cytoplasmic membrane [7]. Phagocytosis of apoptosing cells is carried out mainly 
by macrophages [11]. When the removal of the apoptotic cells and apoptotic 
bodies by scavengers fails, the apoptotic process transits to secondary necrosis 
[12]. Secondary necrosis involves the activation of self-hydrolytic enzymes, 
swelling of the cell or apoptotic bodies and irrecoverable damage to the 
cytoplasmic membrane, leading to the disassembling of the cell with release of the 
cellular components [11, 13].  
As already mentioned, AIP56 is the protagonist of the phagocytic 
elimination that occurs in photobacteriosis. The toxin activates a mechanism of 
endogenous programmed cell death of the host macrophages and neutrophils, 
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leading to their elimination by apoptosis [14]. One of the consequences of that 
elimination is a lack of functional phagocytes that leads to an insufficient clearance 
of apoptotic cells and apoptotic bodies that eventually lyse by secondary necrosis 
[2, 15]. The phagocyte apoptosis induced by AIP56 proves to be a very effective 
mechanism of amplification of the etiopathogenicity, because it results in two 
effects that act together against the host: evasion of the pathogen from 
phagocytosis, a fundamental defence mechanism, and release of tissue harmful 
molecules by secondary necrosis of the apoptotic phagocytes [2, 15]. 
 
AIP56 and NleC 
Analysis of the AIP56‟s primary structure shows that it has an N-terminal 
cleavable signal peptide of 23 amino acid residues (Figure 1), that is cleaved 
during secretion, originating a mature protein with 497 amino acid residues [14, 
15].  
 
Figure 1. Schematic representation of AIP56 and NleC. Slashed box represents the AIP56‟s signal peptide. 
The conserved zinc-metalloprotease signature (HExxH) and the cysteine residues are represented and 
numbered at their relative positions. The disulfide bridge between cysteine 262 and 298 of AIP56 is depicted. 
Adapted from [15].  
Homology analysis showed that the N-terminal region of AIP56 (first 324 
amino acids) is homologous to the non-LEE (locus of enterocyte effacement) 
encoded type III secreted effector C (NleC) conserved in many pathogenic enteric 
bacteria (like enteropathogenic Escherichia coli (EPEC), enterohemorrhagic 
Escherichia coli (EHEC), Salmonella enterica and Citrobacter rodentium) while the 
C-terminal of AIP56 is homologous to an unknown protein of the temperate 
lambda-like bacteriophage APSE-2, suggesting that AIP56 is a two-domain 
protein. The two-domain structure of AIP56 was confirmed by limited proteolysis of 
the toxin with chymotrypsin. Controlled digestion of AIP56 with chymotrypsin 
originates two fragments, resulting from cleavage between F285 and F286 [15]. 
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These fragments are consistent with the domains predicted by homology analysis 
and were found to remain linked by a disulfide bridge between C268 and C298 
(Figure 1) [15]. 
An important feature of AIP56 is the presence of the zinc-binding signature 
HExxH that is typical of most zinc metallopeptidases (Figure 1). This signature is 
present in the AIP56 N-terminal domain and is conserved in the NleC. This 
information led to the hypothesis that AIP56 is an AB-toxin, having an A domain 
(N-terminal domain) exhibiting metalloprotease activity connected to a B domain 
(C-terminal domain) by a disulfide bridge [15]. AB–toxins are so named because 
they consist of two parts, an A component that is the active catalytic domain and a 
B component that binds to the surface of the host cell membrane, allowing the 
entry of the A domain into the cell. Most AB-toxins are endocytosed, and 
translocate from the endosomal compartment or endoplasmic reticulum to the 
cytosol, while others bind to the host cell and the A component subsequently 
passes directly through the host cell‟s membrane and enters the cytoplasm [16]. 
NleC is a type-III secreted zinc metalloprotease targeting the transcription 
factor NF-kB [17-20], which function is to regulate the inflammatory and apoptotic 
response [21, 22] (Figure 2). The homo- or heterodimeric NF-kB complexes are 
composed by two of five related proteins, among them p-65. Normally, NF-kB 
dimers are retained in the cytoplasm by association with inhibitory proteins termed 
IkBs. Due to different stimuli, the IkBs are phosphorylated by IkBs kinases (IKK). 
This triggers IkB ubiquitination, leading to its proteasome-dependent degradation 
and consequently allowing translocation of the free NF-kBs to the nucleus [23, 24]. 
NF-kB is the main signalling pathway employed by the host cells to respond to 
microbial threats [25]. The most important activators of the microbial-induced NF-
kB are the pattern recognition receptors (PRRs), a set of transmembrane or 
intracytoplasmic receptors that specifically recognize and bind different microbial 
macromolecular ligands named microbial-associated molecular patterns (MAMPs), 
such as lipopolysaccharide (LPS), flagelin, peptidoglycans and microbial nucleic 
acids [25]. The cytokines and MAMPs activate NF-kB, by engagement of their 
cognate cells‟ surface receptors. In the nucleus, NF-kBs in their active forms, bind 
to the DNA and activate expression of genes that mediate release of antimicrobial 
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molecules, cytokines, chemokines, adhesion molecules or receptors involved in 
immune recognition process [25]. The inflammatory cascade begins when 
recognition of MAMPs by local cells results in NF-kB activation and consequent 
release of cytokines that promote macrophage re-localization and activation at the 
site of infection. Together, antimicrobial molecules and recruited macrophages 
cooperate to kill pathogens, clear infection, and remove dead cells [25]. 
 
Figure 2. Schematic representation of the NF-kB pathway. Stimulus activation of IKK leads to the 
phosphorylation and consequent ubiquitination of IkB, that enters into proteasome degradation and frees the 
NF-kB, which translocates to the nucleus, bind the DNA and activate the expression of genes involved in the 
inflammatory and anti-apoptotic responses.   
In addition to activating the expression of genes involved in the control of 
the immune and inflammatory response, the NF-κB pathway is also a key mediator 
of genes involved in the inhibition of apoptosis, including the cellular inhibitors of 
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apoptosis (c-IAP1, c-IAP2, and XIAP), the tumor necrosis factor (TNF) receptor-
associated factors (TRAF1 and TRAF2), the Bcl-2  homologues A1/Bfl-1, Bcl-XL 
and IEX-1L [22, 26, 27]. The antiapoptotic proteins block the activation of 
caspases involved in the apoptotic pathway [27], induced by TNF and other stimuli 
[28].  
NleC has been found to inhibit p-65 through its cleavage at the N-terminus. 
The inactivation of the p-65 subunit of NF-kB is followed by proteasomal 
degradation, leading to the loss of its transcriptional activity, and to the failure of 
the immunological process in the cells, resulting in their inability to fight infection 
[17-20, 29].  
Although no substrates for AIP56 were identified when the present work 
started, the above described homology between the N-terminal domain of AIP56 
and the NleC suggested that both proteins could have a common substrate, that 
is, that AIP56 also targets and inactivates NF-kB p-65, compromising the anti-
apoptotic response of the affected host cells and leading to their elimination by 
apoptosis. 
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The biological activity of AIP56 has been studied using primary cultures of 
fish leukocytes, because there are no macrophage cell lines from susceptible fish 
and it has been found that AIP56 does not induces apoptosis in mammalian cell 
lines. This specificity could be due to the existence of receptors for AIP56 in 
phagocytes of susceptible hosts and their absence in mammalian cells. 
Therefore, we hypothesized that if AIP56 was able to enter mammalian cells, it 
would be able to induce apoptosis in those cells. A mammalian cell model for 
studying AIP56 activity would be very advantageous, because there are more 
tools (antibodies and subcellular markers, for example) available to study 
mammalian cells than sea bass cells. 
This study aimed at developing a mammalian cell model to study AIP56 
activity. To achieve this goal, the following strategies were followed: 
1. Intracellular delivery of AIP56-related proteins by transfection and 
establishment of stable-transfected cell lines. 
2. Intracellular delivery of AIP56 subunits using the LF-PA system of 
Bacillus anthracis 
12 
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In vitro cleavage of NF-kB p-65 by AIP56 
 
Cell culture  
HeLa Tet-On cells (Clontech) were maintained in Dulbecco‟s Eagle‟s 
Medium (DMEM; Gibco), with 10 % Fetal Bovine Serum Tetracycline Free (FBS 
Tet-Free; Clontech), 1% G418 (Gibco) and 1% Penicillin-Streptomycin (PenStrep; 
Lonza), at 37ºC in humid atmosphere with 5% CO2. Cells were subcultured 
whenever approximately 75% confluence was reached. 
 
Preparation of cell lysates and in vitro cleavage assays  
The cells were lysed with lysis buffer (10 mM Tris-HCl pH 8.0, 0.5% Triton-
X-100, 150 mM NaCl, 10% glycerol), with the proportion of 20 µl per 1.0x106 cells 
and centrifuged at 16100 x g, for 15 minutes (min) at 4ºC, and the soluble fractions 
were transferred to new eppendorf tubes. The cleavage of NF-kB p-65 was 
assessed by incubation of 20 µl of HeLa Tet-On cells soluble faction with 0.1 µM 
of AIP56 or AIP56-derived proteins in the presence or absence of 5 mM of the 
metalloprotease inhibitor of 1,10-phenanthroline (Phe), for 3 hours (h) at 22ºC. The 
following proteins were tested: full-length AIP56 (AIP56), a mutated version of 
AIP56 carrying amino-acid substitutions that disrupt the zinc metalloprotease 
signature (AIP56mut), an AIP56 N-terminal truncate corresponding to the putative 
AIP56 A domain (AIP56N) and an AIP56 C-terminal truncate corresponding to the 
putative AIP56 B domain (AIP56C). Recombinant NleC was used as a positive 
control. All the proteins were produced and characterized at the Fish Immunology 
and Vaccinology group of IBMC and have a His-tag at the C-terminus. 
 
SDS-PAGE and western-blotting 
The cell lysates were mixed with Gel Loading Buffer (GLB; 50 mM Tris-HCl, 
pH 8.8, 2% SDS, 10% glycerol, 0.017% bromophenol blue, 2 mM EDTA pH 8.8, 
100 mM DTT) and denatured by heating at 95ºC for 5 min. The proteins were 
resolved in 10% SDS-polyacrylamide gels (Figure 3). 
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Components Running Gel (10%) Stacking Gel 
30% acrylamide / 0.4% 
Bisacrylamide 
5 ml 830 µl 
1.875 M Tris-HCl pH 8.8 6 ml - 
0.6 M Tris-HCl pH 6.8 - 1.05 ml 
H2O 3.84 ml 3.02 ml 
SDS 10% 150.40 ml 50 µl 
TEMED 10.80 µl 3 µl 
10% APS 100.80 µl 25 µl 
Figure 3. Composition of the running and stacking gels 
The gels were mounted in an electrophoresis apparatus and 
electrophoresis buffer (25 mM Tris-Base, 250 mM glycine, 0.1% SDS) was added 
to the top and bottom reservoirs. Samples were loaded into the wells and the gels 
were run at 80 V. 
Proteins in the gels were transferred to nitrocellulose membranes in transfer 
buffer (25 mM Tris-Base, 192 mM glycine, 20% methanol), for 1 h at 21 V. To 
control transfer efficiency, equal loading of the lanes, and to locate the molecular 
weight markers, the membranes were stained with Ponceau S (Sigma). The 
membranes were blocked for 1 h at room temperature (RT) in tris buffered saline 
(TBS; 20 mM Tris-, 137 mM NaCl, pH 7.6) with 0.1% Tween 20 (Sigma; T-TBS) 
and 5% low fat powdered milk. Rabbit antibody anti-c-terminal region of human 
NF-kB p-65 (C20; Santa Cruz-Biotechnology), diluted in T-TBS (1:7500), was 
added to the membrane and incubated with shaking for 1 h at RT. The 
membranes were washed 3 times for 5 min in T-TBS, at RT with shaking, and 
incubated with horseradish peroxidase (HRP)-conjugated anti-rabbit IgG antibody 
(The Binding Site), diluted in T-TBS (1:30000) for 1 h at RT. After 3 washes for 5 
min in T-TBS, at RT with shaking, the reactive bands were detected using 
enhanced chemiluminescence substrate (ECL; SuperSignal® West Pica, Thermo 
Scientific) following the manufacturer‟s instructions. 
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Intracellular delivery of AIP56-related proteins by transfection 
 
To delivery of AIP56 by transfection, we decided to use HeLa Tet-On cells 
that allow us to regulate gene expression adding doxycycline (Dox) to the culture 
medium. The Tet-On system for controlling expression of genes of interest in 
mammalian cells was developed by Hermann Bujard and Manfred Gossen at the 
University of Heidelberg [30] as shown in Figure 4. This system enables to tightly 
and reversibly control expression of proteins with the addition of Dox and is useful 
in in vivo studies when rapid activation of a gene is required.  
The Tet regulatory system is performed by the Tet repressor protein (TetR) 
that negatively regulates the genes of the tetracycline-resistance. TetR blocks 
transcription of these genes by binding to the tet operator sequences (tetO) in the 
absence of Dox. TetR and tetO provide the basis of regulation and induction for 
use in mammalian experimental systems [30]. A “reverse” Tet repressor (rTetR) 
was created by four amino acid changes in TetR, and the combination with the C-
terminal domain of VP16 from Herpes Simplex Virus (HSV), converted the rTetR 
into the reverse tetracycline-controlled transactivator (rtTA), an hybrid protein that 
activates transcription in the presence of Dox [31].   
 
Figure 4. Schematic representation of the regulation of gene expression in response to Dox in a Tet-
On system.  
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The rtTA binds the tetracycline-response element (TRE) that is present in 
the response plasmid, which expresses a gene of interest. The TRE consists of 
seven direct repeats of a 42-bp sequence containing the tetO, and is located just 
upstream of the minimal cytomegalovirus (CMV) promoter (PminCMV). In this 
system, high levels of the gene of interest are expressed in the presence of the 
system's inducer, the Dox. 
 
Transient transfection 
Cell culture 
HeLa Tet-On cells were maintained in DMEM with 10% FBS Tet-Free at 
37ºC in humid atmosphere with 5% CO2. Cells were subcultured whenever 
approximately 75% confluence was reached. 
 
Plasmid purification 
Vectors for transfection were constructed in the pTRE2hyg2-Myc vector at 
the Fish Immunology and Vaccinology group of the IBMC, as shown in Figure 5. 
They express a hygromycin (Hyg) resistance gene, permitting easy selection of 
stable transfectants and also encode a c-Myc tag, which is incorporated at the N-
terminus of the expressed proteins to screen directly for protein expression by 
western-blotting and immunofluorescence (IF). A Tet-responsive promoter (PhCMV-
1) is also present in the vectors [30-34]. 
 
Figure 5. Schematic representation of the pTRE2hyg2-Myc vector 
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In this work, the following plasmids were used: 
 pTRE2hyg2-Myc-AIP56: coding for c-Myc tagged full length AIP56 
(AIP56). 
 pTRE2hyg2-Myc-AIP56mutAAIVA: coding for c-Myc-tagged mutated 
version of AIP56 (AIP56mut) carrying amino-acid substitutions that 
disrupt the zinc metalloprotease signature (HEXXH). The mutations 
consist on the substitution by alanines of the key residues for zinc ion 
coordination and water molecule activation: His165, Glu166, His169 
and His170. 
 pTRE2hyg2-Myc-AIP56N: coding for c-Myc-tagged AIP561-285 (Asn1 
to Phe285; AIP56N) corresponding to the putative AIP56 A domain. 
 pTRE2hyg2-Myc-AIP56NmutAAIVA: coding for c-Myc-tagged mutated 
version of putative AIP56  A domain (AIP56Nmut). 
 pTRE2hyg2-Myc-AIP56C: coding for c-Myc-tagged AIP56286-497 
(Phe286 to Asn497; AIP56C) corresponding to the putative AIP56 B 
domain. 
 pTRE2hyg2-Myc-NleC: plasmid coding for c-Myc-tagged non-locus 
of enterocyte effacement encoded type III secreted effector C (NleC). 
 
Escherichia coli XLI were transformed with the different plasmids, by the 
heat and shock method. Transformants were plated in luria bertani (LB)-agar 
plates containing 150 µg/ml ampicillin and incubated overnight (ON) at 37ºC. On 
the next day, starter cultures were made from single colonies that were picked and 
inoculated in LB medium containing ampicillin and incubated approximately 8 h at 
37°C with shaking (170 rpm). The starter cultures were used to inoculate 500 ml of 
fresh medium containing ampicillin. The culture was were grown at 37°C ON, with 
shaking (170 rpm), and the plasmids were purified according to the protocol of the 
commercial QIAGEN® Plasmid Maxi Kit. Plasmid DNA concentrations were 
determined by measuring the absorbances at 260nm (A260), and protein 
contamination was accessed by determining the A280/A260 ratio. 
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Determination of effective concentrations of doxycycline 
The effective concentrations of Dox may vary with different cell lines and 
with different lots of antibiotic. Therefore, it is important to titrate the optimal 
concentration for full activation of gene expression. For this, a Dox dose-response 
curve was performed using the U2-OS-Luc Tet-On Cell Line provided with the Tet-
On advanced kit. This premade double-stable Tet-On Cell Line can exhibit over 
500-fold induction of luciferase upon addition of Dox to the culture medium. 
The U2-OS-Luc Tet-On cells were plated at density of 3x105 cells in each 
well of a 6-well plate containing 3 ml of complete medium (DMEM, with 10% FBS 
Tet-Free, 100 µg/ml Hyg, 1% G418 and 1% PenStrep) plus varying amounts 
(0.1x10-3, 1x10-2, 0.1, 1.0, 10, 100 and 1000 ng/ml) of Dox. The cells were allowed 
to grow at 37ºC in humid atmosphere with 5% CO2 for 48 h, washed and lysed 
according to the protocol of the Luciferase Assay System (Promega). Briefly, 100 
µl of lysis buffer were added to the adherent cells, and the cells were scrapped 
from the wells and transferred to microcentrifuge tubes. The lysates were 
centrifuged at 12000 x g for 2 min at 4ºC, the supernatants collected, transferred 
to wells of a 96-well opaque plate containing the Luciferase Assay Reagent and 
mixed. Luciferase activity was measured in a Microplate luminometer (Lmax™) 
programed to perform a 2 second (sec) measurement delay followed by a 10 sec 
measurement read for luciferase activity. 
 
Chemical transfections  
To perform the transfections, we decided to use the FuGENE® HD 
Transfection Reagent (Roche), a nonliposomal method involving the formation of a 
complex with DNA and the transport of the complex into the cell.  
Optimization Transfection Reagent:DNA ratio and incubation time 
To try to achieve maximum efficiency of transfection, we optimized the ratio 
of FuGENE® HD Transfection Reagent to DNA and the time of incubation of the 
FuGENE® HD Transfection Reagent with DNA. 
In a first approach, we transfected the cells with the plasmid coding for 
luciferase (pTRE2hyg2-Myc-Luc) using FuGENE® HD Transfection Reagent:DNA 
ratios between 1.5:1 to 4:1. One day before the transfection assay, the cells 
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monolayers were washed, trypsinized and plated in wells of a 12-well plate at 
density of 1.5×105 cells per well in 1 ml of medium (DMEM with 10% FBS Tet-
Free), and incubated 24 h in humid atmosphere with 5% CO2, to achieve 
approximately 80% confluence at the time of transfection. 
The plasmid DNA was diluted in DMEM at a final concentration of 0.02 
µg/µl and added to the FuGENE® HD Transfection Reagent, as shown in Figure 
6. 
Transfection 
reagent:DNA 
(µl:µg) 
Diluent 
(DMEM) (µl) 
FuGENE® HD 
Transfection 
Reagent (µl) 
DNA (µg) 
1.5:1 50 1.5 1 
2.0:1 50 2.0 1 
2.5:1 50 2.5 1 
3.0:1 50 3.0 1 
3.5:1 50 3.5 1 
4.0:1 50 4.0 1 
Figure 6. Preparation of transfection complexes for a 12-well  
The transfection reagent:DNA complexes were incubated  for 10, 15, 30 
and 45 min at RT before being added to the cells. After incubation for 24 h at 37ºC 
in humid atmosphere with 5% CO2, the cells were washed, and then the medium 
with the transfection complex was changed to complete medium (DMEM, 10% 
FBS Tet-Free, 1% G418 and 1% PenStrep) with Dox (100 ng/ml) and the cells 
incubated for further 24 h. Transfection efficiency was determined by measuring 
the luciferase expression. 
Transfection efficiency was determined by measuring the luciferase 
expression. To prepare the cell lysates, the cells were washed and lysed with lysis 
buffer (10 mM Tris-HCl pH 8.0, 0.5% Triton X-100, 150 mM NaCl, 10% glycerol; 
20 µl per 1.0x106 cells) and centrifuged at 16100 x g for 15 min at 4ºC. The 
supernatants were diluted 1:1000 in distilled H2O. Twenty microliters of each 
supernatant dilution were transferred to wells of a 96-well opaque plate containing 
the Luciferase Assay Reagent and luciferase activity was measured as described 
before. 
22 
 
In a second approach, we transfected the cells with the plasmids coding for 
AIP56 (pTRE2hyg2-Myc-AIP56), AIP56Nmut (pTRE2hyg2-Myc-AIP56Nmut) and 
AIP56C (pTRE2hyg2-Myc-AIP56C) with FuGENE® HD Transfection 
Reagent:DNA ratios of 3.5:1, 4:1 and 5:2. The transfection was performed as 
described above. Transfection efficiencies were evaluated by IF, as described 
below. 
Optimization of the transfection protocol 
In an attempt to increase the efficiency of transfection, we transfected the 
cells using three different protocols:  
(1) Standard transfection:  a cell monolayer was washed, trypsinized and 
plated in wells of a 12-well plate with sterile cover slips, at density of 1.5x105 cells 
per well in 1 ml of medium (DMEM with 10% FBS Tet-Free), incubated 24 h in 
humid atmosphere with 5% CO2, to achieve approximately 80% confluence at the 
time of transfection. This protocol is the one recommended by the FuGENE® HD 
Transfection Reagent manufacture. 
(2) Transfected of fresh trypsinized cells: a cell monolayer was washed, 
trypsinized and plated at density of 2x105 cells per well, as in (1), incubated 1 h in 
humid atmosphere with 5% CO2, and transfected. 
(3) Transfection of fresh trypsinized cells in suspension: a cell 
monolayer was washed and trypsinized; 2x105 cells were transferred to eppendorf 
tubes and collected by centrifugation at 800 g for 2 min at RT. Each cell pellet was 
resuspended in 25 µl of DMEM, transferred to a tube containing the transfection 
complex in 25 µl of DMEM and the suspension incubated at RT for 15 min, before 
being plated in wells of a 12-well plate with sterile cover slips. This method was 
developed by M. Zhang et al. [35].  
To prepare transfection complexes, 1 µg of DNA was diluted in 50 (for 
protocols 1 and 2) or 25 (for protocol 3) µl DMEM and then added to 3.5 µl of 
FuGENE® HD Transfection Reagent. The transfection reagent:DNA complexes 
were incubated  for 45 min at RT, before being used for transfections. Plates with 
transfected cells were incubated at 37ºC in humid atmosphere with 5% CO2 for 24 
h, washed, and then the medium with the transfection complexes replaced by 
complete medium with Dox. The cells were incubated at 37ºC in humid 
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atmosphere with 5% CO2 for further 24 h. Transfection efficiencies  were 
evaluated by IF, as described below. 
 
Physical transfection  
Electroporation with Nucleofector™ Kit R (Lonza) 
Nucleofector™ method is based on two components, the Nucleofector™ 
Device that induces the optimized electrical parameters for electroporation, in 
aluminium cuvettes, and Nucleofector™ Kit, which contains a specific 
Nucleofector™ solution and a supplement. To prepare the transfection solution to 
be used in the Nucleofector™ method, 18 µl of supplement was mixed with 82 µl 
of Nucleofector™ solution in a microcentrifuge tube according to manufacturer‟s 
instructions. 
Cells at sub-confluence were trypsinized and cell pellets collected by 
centrifugation at 200 x g for 10 min at RT. Then, each cell pellet, containing 6x105 
cells, was resuspended in 100 μl of the transfection solution. Two micrograms of 
plasmid DNA (pTRE2hyg2-Myc-AIP56mut, pTRE2hyg2-Myc-AIP56N, pTRE2hyg2-
Myc-AIP56Nmut and pTRE2hyg2-Myc-AIP56C) were added to each tube and the 
cell suspension was transferred into a cuvette and submitted to electroporation 
(Nucleofector™ I Device, Nucleofector™ program I-013, for high expression level). 
The addgene plasmid 11347, (for constitutive expression of GFP-tagged non-
muscle myosin heavy chain IIA), kindly provided by the Molecular Microbiology 
Group of IBMC, was used as a positive control. After electroporation, 500 μl of pre-
warmed medium was added to the cell suspension. Duplicate aliquots of 300 µl of 
the resulting cell suspension were transferred to wells of a 12-well plate containing 
sterile coverslips and previously loaded with 700 μl of medium (DMEM with 10% 
FBS Tet-Free). The plates were incubated at 37ºC in humid atmosphere with 5% 
CO2 for 24 h, washed, and then the medium with the transfection complex 
replaced by complete medium with Dox. The cells were incubated at 37ºC in 
humid atmosphere with 5% CO2 for further 24 h. Transfection efficiencies  were 
evaluated by IF, as described below. 
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Immunofluorescence 
For IF, cells were washed and fixed with freshly prepared 4% 
paraformaldehyde (Merck) in phosphate buffered saline (PBS; Lonza), for 10 min. 
Fixed cells were washed and permeabilized with 0.1% Triton X-100 in PBS for 10 
min. The cells were incubated for 30 min in blocking solution (10% FBS, 0.1% 
Tween 20, in PBS), followed by incubation with a mouse anti-c-Myc antibody 
(Santa Cruz Biotechnology) diluted in blocking solution (1:50), for 1 h at RT in a 
wet chamber, and then washed 3 times for 5 min in PBS, at RT. An Alexa Fluor® 
488 goat anti-mouse antibody (Invitrogen, Molecular Probes), diluted in blocking 
solution (1:2000) was used as a secondary antibody together with the actin stain 
Alexa Fluor® 594 Phalloidin (Invitrogen, Molecular Probes) diluted in blocking 
solution (1:40). Incubation last for 1 h at RT in a wet chamber and in the dark. The 
slides were washed 3 times for 5 min in PBS at RT before being counterstained 
with 0.2 µg/ml of DAPI, in a wet chamber and in the dark. Slides were mounted 
with Vectashield® Mounting Media and analysed under a Zeiss AxioImager Z1 
fluorescence microscope. Images were captured using an Axiocam MR Version 
3.0 (Carl Zeiss, Germany). Cells from 10 randomly selected microscope fields 
were counted.  
 
Stable transfection 
Titration of hygromycin 
Prior to use Hyg to establish stable cell lines, it is important to titrate the 
selection agent stocks to determine the optimal concentration for selection of 
resistant cells.  
For titration of Hyg, the HeLa Tet-On cells were plated at density of 6x105 
cells in each of six 10 cm tissue culture dishes containing 10 ml of complete 
medium (DMEM, with 10% FBS Tet-Free, 1% G418 and 1% PenStrep) plus 
varying concentrations (0, 50, 100, 200, 400, 800 μg/ml) of Hyg. The cells were 
incubated for 14 days at 37ºC in humid atmosphere with 5% CO2, replacing the 
selective medium every four days. The dishes were examined for the presence of 
viable cells every two days. At day 5, the plates were photographed under a Zeiss 
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Axiovert 200M inverted microscope using the 20 x objective. Cells from 6 
randomly selected microscope fields were counted. 
 
Transfection  
To establish stable-transfected cell lines, freshly trypsinized HeLa Tet-On 
cells were transfected in suspension with FuGENE® HD Transfection Reagent, 
plated in wells of a 6-well plate and subjected to selection with Hyg. 
To prepare transfection complexes, 2 µg of DNA was diluted in 50 µl of 
DMEM and then added to 7 µl of FuGENE® HD Transfection Reagent. The 
transfection reagent:DNA complexes were incubated  for 45 min at RT, before 
being used for transfections.  
A cell monolayer was washed and trypsinized; 6x105 cells were transferred 
to eppendorf tubes and collected by centrifugation at 800 g for 2 min at RT. Each 
cell pellet was resuspended in 50 µl of DMEM, transferred to a tube containing the 
transfection complex in 50 µl of DMEM and the suspension incubated at RT for 15 
min, before being plated in wells of a 6-well plate. 
Plates with transfected cells were incubated at 37ºC in humid atmosphere 
with 5% CO2 for 24 h, washed, and then the medium with the transfection 
complexes replaced by selective medium (DMEM, 10% FBS Tet-Free, 1% G418, 
1% PenStrep and 50 µg/ml Hyg), and the plates were incubated again at 37ºC in 
humid atmosphere with 5% CO2. The medium was replaced with fresh selective 
medium with Hyg every four days, until resistant cell colonies began to appear. 
 
Intracellular delivery of AIP56 subunits using the LF-PA of system 
Bacillus anthracis 
 
Cell culture 
Raw 264.7 cells were maintained in DMEM with 10% FBS at 37ºC in humid 
atmosphere with 5% CO2. Cells were sub-cultured whenever approximately 95% 
confluence was reached. 
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Delivery of AIP56 subunits  
In this work, the following chimeric proteins were used: LFN, consisting of 
the anthrax protective antigen (PA) recognition domain of anthrax lethal factor 
(LF1-254) fused with putative AIP56 A domain (AIP56N1-261) and LFC, consisting of 
LF1-254 fused with putative AIP56 B domain (AIP56C299-497). All the proteins were 
produced and are available at the Fish Immunology and Vaccinology group of 
IBMC. 
One day before the assay, the cells were plated in a 96-well plate (2x104 
cells/well). The fusion proteins (20 nM LFN or 20 nM LFC,) were added to the cells 
together with the 10 nM PA and cells were incubated for 6 h at 37ºC in humid 
atmosphere with 5% CO2. 
 
SDS-PAGE and western-blotting 
To obtain cell lysates, cells were washed 3 times with PBS and lysed with 
GLB. DTT was added to the lysates at a final concentration of 100 mM, and the 
proteins denatured by heating at 95ºC for 5 min and resolved in 10% SDS-
polyacrylamide gels, as described above. 
Proteins in the gels were transferred to nitrocellulose membranes in transfer 
buffer, for 1 h at 21 V. To control transfer efficiency, equal loading of the lanes, 
and to locate the molecular weight markers, the membranes were stained with 
Ponceau S. The membranes were blocked for 1 h at RT in T-TBS and 5% low fat 
powdered milk and incubated for another hour at RT with shaking with rabbit anti-
NF-kB p-65 antibody (C20;Santa Cruz Biotech), diluted in T-TBS (1:3000), washed 
3 times for 5 min in T-TBS, at RT with shaking and incubated with HRP anti-rabbit 
IgG antibody (The Binding Site), diluted in T-TBS (1:30000), for 1 h at RT, with 
shaking. The membranes were washed again 3 times for 5 min in T-TBS, at RT 
with shaking, and the reactive bands were detected using ECL following the 
manufacturer‟s instructions. 
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Results and Discussion 
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 In vitro cleavage of NF-kB p-65 by AIP56 
In the beginning of this work there was a hypothesis that AIP56 was not 
internalized by mammalian cells, possibly due to lack of specific membrane 
receptors able to bind the toxin. That hypothesis came from the fact that when 
AIP56 was incubated with different mammalian cell lines, there were no signs of 
apoptosis and no toxin could be detected associated to the cells. Considering the 
homology between AIP56 N-terminal domain and NleC, a type-III secreted effector 
found in enteric bacteria pathogenic to mammals, it was further hypothesised that 
both bacterial proteins could have common targets/substrates. Therefore, when, 
during the course of this work, NF-kB p-65 was identified as a substrate of the 
NleC [17-20], we decided to investigate the ability of AIP56 to cleave the 
mammalian NF-kB p-65. 
To elucidate the AIP56 proteolytic activity against NF-kB p-65, we carried 
out in vitro cleavage assays. HeLa Tet-On cell lysates were incubated with AIP56 
or AIP56 related proteins and the NF-kB p-65 cleavage assessed by western-
blotting (Figure 7). 
 
Figure 7. AIP56 cleaves mammalian NF-kB p-65 in vitro. Western blot of HeLa Tet-On cell lysates 
incubated with the indicated proteins for 3 h in the presence or absence of 5 mM of the metallopeptidase 
inhibitor 1,10-phenanthroline (Phe). 
 
We found that AIP56, similarly to what has been described for NleC, 
cleaves NF-kB p-65 and that cleavage is inhibited by the metallopeptidase inhibitor 
1,10- phenanthroline (Figure 7). Using the AIP56mut (AIP56 mutated in the 
metalloprotease signature), we also found that amino-acid substitutions in the zinc 
metalloprotease signature of the toxin abolished its proteolytic activity, confirming 
that cleavage of NF-kB p-65 by AIP56 is dependent on the metalloprotease activity 
of the toxin. In line with this conclusion are the results obtained with the AIP56 
truncates, showing that the AIP56N (corresponding to the putative AIP56 A 
domain) retains the ability to cleave NF-kB p-65, whereas the AIP56C 
(corresponding to the putative AIP56 B domain) does not.  
30 
 
The identification of NF-kB p-65 as a substrate for AIP56 opens many 
prospects in what concerns the study of the AIP56‟s activities. Using NF-kB p-65 
cleavage as an indication of AIP56 activity has already allowed the re-evaluation 
of the interaction of AIP56 with mammalian cell lines. Results obtained at the Fish 
Immunology and Vaccinology group of the IBMC show that, contrarily to what has 
been initially hypothesized, AIP56 is able to enter and cleave the NF-kB p-65 in 
several mammalian cell lines (HeLa, Caco-2, J774A.1, Raw 264.7), despite no 
apoptosis of those cells was observed after incubation with the toxin.  
 
Intracellular delivery of AIP56-related proteins by transfection 
 
Preliminary titrations 
Prior to establish a transfection protocol with Tet-On cells, it is important to 
titrate the concentration of doxycycline (Dox) for optimal induction of gene 
expression as well as the concentration of hygromycin (Hyg) to be used in the 
selection of transfected cells when stable transfected cell lines are to be 
developed. 
The Dox is used to induce the expression of the gene of interest. In order to 
determine the Dox concentration yielding the maximum expression of the required 
proteins, the expression of the luciferase in U2-OS-Luc cells was induced with 
different doses of Dox, and the luciferase expression quantified by luminescence 
at 48 h post-induction.  
The highest luciferase activity was obtained with 100 ng/ml of Dox (Figure 
8) and, therefore, this concentration was selected for further experiments.  
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Figure 8. Doxycyclin dose-response assay. U2-OS-Luc Tet-On cells were plated at density of 3x10
5
 cells in 
each well of a 6-well plate in the presence of the indicated Dox concentrations. The cells were incubated 48 h, 
lysed, and the luciferase activity quantified by luminescence and expressed as relative luminescence units 
(RLU). Results shown are representative of 5 independent experiments 
 
The Hyg is an antibiotic used to establish stable cell lines. The transfected 
cells have the plasmid that encodes for Hyg resistance. To choose the ideal 
concentration of Hyg, a dose response assay with different concentrations of 
antibiotic was performed. The optimal concentration is the lowest concentration 
that begins to induce massive cell dead, in non-transfected cells, at day 5 and kills 
all the cells within 14 days. These criteria gave the guidelines to choose the 
concentration that is enough to kill the cells without resistance (non-transfected) 
and not in excess to kill by toxicity the resistant transfected cells. 
In Figure 9, the obtained kill curve is depicted, showing that 50 µg/ml Hyg 
induce approximately 50% cell dead at the 5th day. When incubated with this 
concentration of Hyg, no viable cells were present at day 14th (data not shown). 
Considering these results a Hyg concentration of 50 µg/ml was chosen for 
subsequent experiments.  
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Figure 9. Hygromycin dose response assay. U2-OS-Luc Tet-On cells were plated at density of 6x10
5
 cells 
in 10 cm culture dishes with the indicated concentrations of Hyg and incubated up to 14 days. The results 
represent the viable cells counted at day 5, expressed in percentage relative to control cells (incubated in the 
absence of Hyg). Results shown are representative of 4 independent experiments. 
                                                                         
Chemical transfection 
Effect of transfection reagent:DNA ratio 
In this work, chemical transfections were done using FuGENE® HD 
Transfection Reagent, a reagent that forms a complex with the plasmid DNA, and 
then transports the complex into cells. It is known that the transfection 
reagent:DNA ratio can influence the efficiency of transfection [36, 37]. To 
maximize the efficiency of transfection, optimization experiments, using different 
ratios of FuGENE® HD Transfection Reagent to DNA were performed. In a first 
approach, different ratios were compared using the plasmid coding for luciferase 
(pTRE2hyg2-Myc-Luc) for transfections and measuring the luciferase activity after 
24 h of Dox induction. 
33 
 
 
Figure 10. Optimization of the FuGene® HD Transfection Reagent:DNA ratio using pTRE2hyg2-Myc-
Luc . Hela Tet-On cells were plated at density of 1.5×10
5
 cells in each well of a 12-well plate with DMEM with 
10% FBS Tet-Free and then transfected with the pTRE2hyg2-Myc-Luc by incubation with the indicated 
transfection Reagent:DNA ratios. After incubation for 24 h cells were induced with Dox (100 ng/ml), incubated 
for 24 h, lysed, and the luciferase activity quantified by luminescence and expressed as relative luminescence 
units (RLU). 
The results show that the highest efficiency of transfection (resulting in the 
highest luciferase activity), was obtained with 3.5:1 transfection reagent:DNA ratio 
(Figure 10). In a second approach, the effect of the FuGENE® HD Transfection 
Reagent to DNA ratio was evaluated using plasmids pTRE2hyg2-Myc-AIP56, 
pTRE2hyg2-Myc-AIP56Nmut or pTRE2hyg2-Myc-AIP56C, using transfection 
reagent:DNA ratios of 3.5:1, 4.0:1 and 5.0:2.  Regardless of the plasmid used, the 
highest percentage of transfected cells was obtained using the Transfection 
Reagent:DNA ratio of 3.5:1 (Figure 11), in accordance with the results obtained in 
the preliminary experiments with plasmid pTRE2hyg2-Myc-Luc (Figure 10).   
 
Effect of incubation time of the transfection complexes 
Because formation of the complexes involves interactions between the 
transfection reagent and the DNA [37], and also because the size of micelles has 
implication for the transfection [38], different incubation times (10, 15, 30, 45 min) 
of the transfection reagent:DNA complexes were tested, in order to determine the 
incubation time leading to the highest efficiency of transfection. 
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Immunofluorescence analysis of transfected cells showed that maximum efficiency 
of transfection was obtained when the transfection reagent:DNA complexes were 
incubated for 45 min, as compared to complexes incubated for 10, 15 and 30 min 
(data not shown). 
 
Optimization of the transfection protocol 
The transfection efficiency is crucial to obtain stable cell lines, because if 
the transfection has low efficiency, few cells will be selected to resist at the time of 
the selection with Hyg, therefore cells won‟t be enough to remain viable and form 
clones. It is usually considered that a suitable performance is 50% of transfected 
cells. 
In the current work, when we performed the transfection using FuGENE® 
HD according to the manufacturer‟s instructions (protocol 1), regardless the 
transfection reagent:DNA ratio, transfection of HeLa Tet-On cells with pTRE2hyg2-
Myc-AIP56, pTRE2hyg2-Myc-AIP56Nmut or pTRE2hyg2-Myc-AIP56C always 
resulted in less than 50% transfected cells, as assessed by positive IF staining 
(Figure 11). Regardless of the plasmid used, the highest percentage of transfected 
cells was obtained using the Transfection Reagent:DNA ratio of 3.5:1, and for this 
ratio, the highest percentage of transfected cells (36.57%) was obtained with 
plasmid pTRE2hyg2-Myc-AIP56C, while transfection with plasmids pTRE2hyg2-
Myc-AIP56AIP56 and pTRE2hyg2-Myc-AIP56Nmut resulted in 21.71% and 
17.84% transfected cells, respectively (Figure 11). The low efficiency of 
transfection can result from the fact that the receiver cells are killed due to injuries 
occurred during the transfection process or the complexes undergo lysosomal 
degradation [39, 40]. It can also be that the plasmids stay in the nucleus as an 
episomal DNA, without integrate into the host genome; these molecules in dividing 
cells do not replicate and are eventually diluted away as the population of 
replicating cells grows [39]. 
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Transfection 
reagent:DNA  
(µl:µg) 
Efficiency of transfection (%) 
pTRE2hyg2-
Myc-AIP56 
pTRE2hyg2-
Myc-AIP56Nmut 
pTRE2hyg2-
Myc-AIP56C 
3.5:1 21.71 17.84 36.57 
4.0:1 17.66 14.31 28.58 
5.0:2 9.25 7.41 12.89 
(B)    
 
Figure 11. Effect of the FuGENE® HD Transfection Reagent:DNA ratios in the efficiency of transfection 
(A) Immunofluorescence analysis of the expression of AIP56Nmut in HeLa Tet-On cells transfected with 
pTRE2hyg2-Myc-AIP56Nmut using a (a) 3.5:1, (b) 4:1 or (c) 5:2 ratio of FuGENE® HD Transfection 
Reagent:DNA. After incubation for 24 h, transfected cells were induced with 100 ng/ml Dox for 24 h, fixed and 
processed for IF. The c-myc-tagged AIP56Nmut appears in green, nuclei were counterstained with DAPI 
(blue) and the actin cytoskeleton with Alexa Fluor® 594 Phalloidin (red). (B) Table summarizing the 
transfection efficiencies obtained for different plasmids and different FuGENE® HD Transfection 
Reagent:DNA ratios. Images obtained as in panel A served as the basis for quantifications.  
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The different efficiencies obtained with different plasmids may be related to 
the Zeta Potential, as described by S. Yamano et al. [41], because different 
plasmids interact with the lipids of the reagent and form complexes with different 
charges and these differences can affect the efficiency of the interaction of the 
complexes with the cell membrane.  
Considering that the experiments performed with the FuGENE® HD 
Transfection Reagent using the standard protocol (protocol 1) always resulted in 
less than 50% transfected cells, we decided to optimize the transfection protocol in 
an attempt to obtain higher efficiencies of transfection. One of the approaches 
(protocol 2) consisted in doing the transfection essentially as described in the 
FuGENE® HD Transfection Reagent manual, but using freshly trypsinized cells (1 
h after plating) instead of cells plated 24 h before. Using this method, the 
efficiencies increased slightly, but regardless of the plasmid used, did not reach 
the 50% transfected cells, as shown in Figure 12. Similarly to what was observed 
in transfections done using the standard protocol (protocol 1; Figure 11), the 
highest efficiency was obtained in cells transfected with plasmid pTRE2hyg2-Myc-
AIP56C. 
Transfected plasmid Efficiency of transfection (%) 
pTRE2hyg2-Myc-AIP56 24.77 
pTRE2hyg2-Myc-AIP56Nmut 26.65 
pTRE2hyg2-Myc-AIP56C 45.51 
Figure 12. Percentages of transfected cells obtained by transfection of freshly trypsinized cells (1h 
after plating) with the indicated plasmids. Transfected cells were processed for IF and efficiencies of 
transfection determined as described in Figure 11.   
Another approach tested in this work, consisted in transfecting freshly 
trypsinized cells in suspension with the FuGENE® HD Transfection Reagent 
(protocol 3). This protocol was developed by M. Zhang et al. [35], and, according 
to the authors, results in enhanced efficiencies of transfection.  
When we used protocol 3 for transfection, regardless of the plasmid used, 
the percentage of transfected cells increased markedly for values always above 
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50% (Figure 13).  The lowest efficiency of transfection (55.56%) was obtained 
using plasmid pTRE2hyg2-Myc-AIP56, while when plasmids pTRE2hyg2-Myc-
AIP56Nmut and pTRE2hyg2-Myc-AIP56C were used, the efficiencies were 
71.87% and 82.77%, respectively.  
 
 
Transfected plasmid 
Efficiency of 
transfection (%) 
pTRE2hyg2-Myc-
AIP56 
55.56 
pTRE2hyg2-Myc-
AIP56Nmut 
71.87 
pTRE2hyg2-Myc-
AIP56C 
82.77 
 
 
Figure 13. Percentages of transfected cells obtained by transfection of freshly trypsinized cells in 
suspension with the indicated plasmids. (A) Immunofluorescence analysis of expression of AIP56Nmut in 
HeLa Tet-On cells transfected with pTRE2hyg2-Myc-AIP56Nmut using a 3.5:1 ratio of FuGENE® HD 
Transfection reagent:DNA. After incubation for 24 h, transfected cells were induced with 100 ng/ml Dox for 24 
h, fixed and processed for IF. The c-myc tagged AIP56Nmut appears in green, nuclei were counterstained 
with DAPI (blue) and the actin cytoskeleton with Alexa Fluor® 594 Phalloidin (red). (B) Table summarizing the 
transfection efficiencies obtained for different plasmids. Images obtained as in panel A served as the basis for 
quantifications.  
 
Physical transfection 
Exposing eukaryotic cells to brief, high voltage electrical fields can induce 
the uptake of exogenous materials, presumably through the transient formation of 
micropores in the cell membrane [42]. When cells are transfected by 
electroporation, such electrical field is used to alter the cell permeability producing 
transient holes in the cell membrane, through which the DNA can enter [43]. 
In this work, we transfected HeLa Tet-On cells by electroporation with 
plasmids pTRE2hyg2-Myc-AIP56mut, pTRE2hyg2-Myc-AIP56N, pTRE2hyg2-Myc-
AIP56Nmut, pTRE2hyg2-Myc-AIP56C using the Nucleofector™ Kit R. Regardless 
(A) 
(A) 
(B) 
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of the plasmid used for electroporation, few cells were recovered after the process 
and the ones that remained viable were not expressing the myc-tagged proteins, 
as concluded from negative IF staining (Figure 14). This could be due to injuries 
caused to cells during the transfection, because although electroporation is 
considered an efficient method to transfect almost all types of cells with some 
success, it is, at the same time, a severe technique and many cells die in the 
process [39, 44]. 
 
Figure 14.Immunofluorescence analysis of expression of AIP56Nmut in HeLa Tet-On cells transfected 
by electroporation with pTRE2hyg2-Myc-AIP56Nmut (left panel). After transfection, cells were plated, 
incubated for 24 h, induced with 100 ng/ml Dox for 24 h, fixed and processed for IF. Cells transfected with a 
plasmid coding for GFP-tagged NMHC II-A were used as a positive control (right panel). The c-myc tagged 
AIP56Nmut or GFP-tagged NMHC II-A appear in green, nuclei were counterstained with DAPI (blue) and the 
actin cytoskeleton with Alexa Fluor® 594 Phalloidin (red). 
 
Stable transfection 
As already discussed, the success of the establishment of stable-
transfected cells lines is much dependent in the initial number/percentage of 
transfected cells at the time of the selection with the selective agent. The higher 
the number of transfected cells, the higher the probability of success in obtaining 
stable-transfected clones after selection. In an attempt to obtain stable-transfected 
cell lines, we started by using the standard transfection protocol recommended by 
the FuGENE® HD Transfection Reagent manufacturer (protocol 1) followed by 
selection with Hyg, according to the results obtained in the preliminary titration 
assays. However, although some transfected cells remained viable for more than 
two weeks, they did not proliferate to form clones (not shown). This was probably 
because the initial number of transfected cells was too low to allow them to 
proliferate. Therefore, after the above-discussed optimizations of the transfection 
protocol that allowed us to greatly increase the transfection efficiencies, we set up 
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new experiments in which we transfected freshly trypsinized cells in suspension 
with the FuGENE® HD Transfection Reagent and proceeded to selection with 
Hyg. These experiments are currently ongoing and we expect to obtain stable-
transfected clones in the near future. 
 
Intracellular delivery of AIP56 subunits using the LF-PA system of 
Bacillus anthracis 
 
Anthrax toxin is composed of three separate proteins produced by Bacillus 
anthracis: lethal factor (LF), edema factor (EF), and protective antigen (PA). This 
toxin belongs to the family of bacterial binary AB-toxins and is capable of binding 
and entering almost any cell type [45]. PA binds to a cellular receptor, the anthrax 
toxin receptor (ATR), and mediates the delivery of the enzymatic components (LF 
and EF) to the cytosol (Figure 15). PA is cleaved by a furin-like cell-surface 
membrane protease, releasing the PA20 subunit in the extracellular milieu. The 
remaining PA63 subunit oligomerizes to form [PA63]7 that binds a maximum of three 
molecules of LF [46].  
The assembled toxins are endocytosed and tracked to endosomes that are 
moved to a low-pH endosomal compartment where the acidic environment 
induces a conformational change in PA that allows it to insert into the endosome 
membrane and form a pore, promoting the translocation of LF to the cytosol to 
cause death of macrophages [45].  
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Figure 15. Schematic model of Anthrax lethal toxin translocation. Adapted from [46] 
Using fusion proteins containing a portion of LF and the catalytic domains of 
some toxins, it has been demonstrated that amino acid residues 1 to 254 of LF 
(LF1-254) are the minimum region required to recognize and bind the protective 
antigen (PA) and to be sufficient to cause cellular uptake of fused polypeptides 
[47] such as the catalytic domains of diphtheria, shiga and pseudomonas toxins to 
cell cytosol [47-50]. Most cell types possess receptors to the PA, and the 
possibility to construct fusions between the non-catalytic domain of the LF (LF1-254) 
and other proteins, opens the possibility to use the LF-PA system as a vehicle to 
delivery proteins into the cytosol of cells [49-51]. 
In this work we used LFAIP56 chymeric proteins (LFN and LFC) together 
with PA to access the ability of the LF-PA system to deliver the AIP56 catalytic 
domain into the cytosol of Raw 264.7 cells. Figure 16 shows that this system was 
able to efficiently deliver the AIP56 catalytic domain, as confirmed by the NF-kB p-
65 cleavage in cells incubated with PA+LFN. PA+LFC was used as a negative 
control and, as expected, when incubated with cells did not result in NF-kB p-65 
cleavage. 
 
Figure 16. Western blotting analysis of NF-kB p-65 cleavage after incubation of Raw 264.7 cells with 
LFN or LFC in the presence of PA for 6 h. 
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Conclusion 
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During the course of this work, the understanding of the NleC, the N-
terminal homologue of AIP56 has advanced dramatically and NF-kB p-65 was 
reported as NleC‟s first identified substrate. The homology between NleC and 
AIP56 led us to investigate the ability of AIP56 to cleave NF-kB p-65. We found 
that, similarly to NleC, AIP56 cleaves NF-kB p-65, although the relationship 
between the p-65 cleavage and the apoptotic activity of AIP56 remains to be 
elucidated. The identification of NF-kB p-65 as a substrate for AIP56 has already 
allowed the re-evaluation of the interaction of AIP56 with mammalian cell lines 
showing that, contrarily to what has been initially hypothesized, AIP56 is able to 
enter and cleave the NF-kB p-65 in several mammalian cell lines. 
The lack of commercially available tools to study the activity of AIP56 in sea 
bass cells prompted us to develop a mammalian cell model to study the activity of 
the toxin. Different protocols were tested and optimized for the intracellular 
delivery of AIP56 or AIP56-related proteins into mammalian cells and, from the 
results obtained, we can conclude that the most efficient methods for the delivery 
of the proteins were: (1) chemical transfection of HeLa Tet-On cells with toxin-
encoding vectors using FuGENE® HD Transfection Reagent by an alternative 
method for efficiency enhancement, in which freshly trypsinized cells are 
transfected in suspension (in contrast to the standard protocol, in which cells are 
transfected in monolayers 24 h after plating); (2) the use of the LF-PA system of 
Bacillus anthracis. The chemical transfection (either transient or stable) of HeLa 
Tet-On cells may be very advantageous whenever inducible expression of high 
levels of the AIP56 or AIP56-related proteins is necessary, because it allows the 
controlled induction of protein synthesis. In contrast, the LF-PA system of Bacillus 
anthracis may be more suitable when delivery of low amounts of AIP56 or AIP56-
related proteins through a more physiological route is preferable.  
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